GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

tovecimig   Click here for help

GtoPdb Ligand ID: 14507

Synonyms: ABL001 | CTX-009 | CTX009
Compound class: Antibody
Comment: Tovecimig (CTX-009; formerly ABL001) is a bispecific monoclonal antibody that simultaneously blocks the signalling pathways that are activated by the delta-like ligand-4 (DLL4; Notch signaling) and vascular endothelial growth factor A (VEGF-A) [4]. The VEGF-A binding heavy chains of tovecimig are derived from the established anti-VEGF-A biologic bevacizumab. Two single chain variable fragments (scFv) that bind to human DLL4 are linked to the C-termini of the anti-VEGF-A heavy chains [1].
Classification Click here for help
Compound class Antibody
International Nonproprietary Names Click here for help
INN number INN
13128 tovecimig
Synonyms Click here for help
ABL001 | CTX-009 | CTX009
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1654
Other databases
Search PubMed clinical trials tovecimig
Search PubMed titles tovecimig
Search PubMed titles/abstracts tovecimig